These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 14075847)

  • 1. [INFLUENCE OF THE NUMBER OF DOSES ON THE EPIDEMIOLOGICAL EFFICACY OF LIVE VACCINE AGAINST INFLUENZA].
    SMORODINTSEV AA; BUROV SA; DOKUCHAEV GM; MINCHEV PN; FILIPPOV NA; CHALKINA OM
    Vopr Virusol; 1963; 22():286-91. PubMed ID: 14075847
    [No Abstract]   [Full Text] [Related]  

  • 2. [FIELD TRIALS OF LIVE ATTENUATED ASIAN INFLUENZA VIRUS VACCINE (OKUNO VACCINE)].
    GOTOE H
    Sapporo Igaku Zasshi; 1963 Sep; 24():211-5. PubMed ID: 14192251
    [No Abstract]   [Full Text] [Related]  

  • 3. [INVESTIGATIONS ON THE PROBLEM OF THE DETECTION OF LIVE INFLUENZA VACCINES. I. RESULTS OF A TEST OF LIVE A2-INFLUENZA-VACCINES IN A CONTROLLED EXPERIMENT WITH VOLUNTEERS].
    STARKE G; SIEBELIST I; HILLER E
    J Hyg Epidemiol Microbiol Immunol; 1964; 8():37-43. PubMed ID: 14128977
    [No Abstract]   [Full Text] [Related]  

  • 4. COMPARATIVE STUDY OF THE IMMUNOLOGICAL PROPERTIES OF LIVE INFLUENZA VACCINE IN VOLUNTEERS.
    RITOVA VV; ZHUKOVSKY AM; YEVSTIGNEYEVA NA
    J Hyg Epidemiol Microbiol Immunol; 1963; 7():272-80. PubMed ID: 14110339
    [No Abstract]   [Full Text] [Related]  

  • 5. Preliminary results of oral influenza vaccination with live attenuated viruses.
    DeBarbieri A; Crovari P; Cuneo-Crovari P; Badolati G; Giacometti G
    Dev Biol Stand; 1976; 33():213-9. PubMed ID: 782972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and immunogenicity in man of a cell culture derived trivalent live attenuated seasonal influenza vaccine: a Phase I dose escalating study in healthy volunteers.
    Heldens J; Hulskotte E; Voeten T; Breedveld B; Verweij P; van Duijnhoven W; Rudenko L; van Damme P; van den Bosch H
    Vaccine; 2014 Sep; 32(39):5118-24. PubMed ID: 24858566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [DEVELOPMENT OF THE QUADRIVALENT LIVE ATTENUATED INFLUENZA VACCINE INCLUDING TWO INFLUENZA B LINEAGES--VICTORIA AND YAMAGATA].
    Desheva YA; Smolonogina TA; Doroshenko EM; Rudenko LG
    Vopr Virusol; 2016; 61(1):16-20. PubMed ID: 27145595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Application of an interferonogen--oral live influenza vaccine A2B for treating influenza].
    Ostrovskiĭ NN; Vengerov II; Lazukina LN; Koiudenko LG; Alekseeva AK
    Zh Mikrobiol Epidemiol Immunobiol; 1974 Oct; (10):54-6. PubMed ID: 4616545
    [No Abstract]   [Full Text] [Related]  

  • 9. Influenza hemagglutination-inhibition antibody titer as a correlate of vaccine-induced protection.
    Ohmit SE; Petrie JG; Cross RT; Johnson E; Monto AS
    J Infect Dis; 2011 Dec; 204(12):1879-85. PubMed ID: 21998477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of an inhibitor-resistant live attenuated influenza vaccine in normal and asthmatic adults.
    Warshauer DM; Minor TE; Inhorn SL; Reed CE; Dick EC
    Dev Biol Stand; 1976; 33():184-90. PubMed ID: 782967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of the postvaccination level of influenza antibodies by means of the radial immunodiffusion and hemagglutination inhibition reactions].
    Vavilova IuG; Gorev NE; Zykov MP
    Vopr Virusol; 1976; (2):158-61. PubMed ID: 820079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Increase in the effectiveness of anti-influenza immunization by use of a combination of inactivated and live vaccine].
    Smorodintsev AA; Orlov VA; Ermolaeva OM; Zhilova GP
    Vopr Virusol; 1978; (5):602-7. PubMed ID: 735019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Restriction analysis of genome composition of live influenza vaccine].
    Kiseleva IV; Larionova NV; Teley LC; Rudenko LG
    Vopr Virusol; 2011; 56(3):28-32. PubMed ID: 21786624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical trials with intranasally administered WRL 105 strain live influenza vaccine in volunteers.
    Freestone DS
    Dev Biol Stand; 1976; 33():207-12. PubMed ID: 782971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modest Waning of Influenza Vaccine Efficacy and Antibody Titers During the 2007-2008 Influenza Season.
    Petrie JG; Ohmit SE; Truscon R; Johnson E; Braun TM; Levine MZ; Eichelberger MC; Monto AS
    J Infect Dis; 2016 Oct; 214(8):1142-9. PubMed ID: 27095420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Sero-epidemiological investigations of the effectiveness of influenza vaccine with attenuated live viruses of types A2 and B].
    Ivan A; Vancea G; Zvorişteanu V; Oană C; Rusu F; Gherman A; Meleghi M
    Stud Cercet Inframicrobiol; 1968; 19(5):355-61. PubMed ID: 5716054
    [No Abstract]   [Full Text] [Related]  

  • 17. Protective efficacy in mice of monovalent and trivalent live attenuated influenza vaccines in the background of cold-adapted A/X-31 and B/Lee/40 donor strains.
    Jang YH; Lee EY; Byun YH; Jung EJ; Lee YJ; Lee YH; Lee KH; Lee J; Seong BL
    Vaccine; 2014 Jan; 32(5):535-43. PubMed ID: 24342248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity and safety of a quadrivalent live attenuated influenza vaccine in children.
    Block SL; Falloon J; Hirschfield JA; Krilov LR; Dubovsky F; Yi T; Belshe RB
    Pediatr Infect Dis J; 2012 Jul; 31(7):745-51. PubMed ID: 22466322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Criteria in the evaluation of live intranasal influenza virus vaccines.
    Zygraich N
    Dev Biol Stand; 1976; 33():141-50. PubMed ID: 782962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative efficacy of inactivated and live attenuated influenza vaccines.
    Monto AS; Ohmit SE; Petrie JG; Johnson E; Truscon R; Teich E; Rotthoff J; Boulton M; Victor JC
    N Engl J Med; 2009 Sep; 361(13):1260-7. PubMed ID: 19776407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.